Delivery Order SPE2DB22D2206-SPE2DB24FHX96

Award Date 6/26/24
Potential Completion Date 6/27/24
Potential Value $7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,547.16 firm fixed-price delivery order is for the supply of Cetirizine HCL 5 mg tablets, with a period of performance through June 2024. Amerisourcebergen holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,477.05 firm fixed-price delivery order is for the provision of 4,567,502,085 tablets of Cetirizine HCL 5 mg, with a period of performance through March 10, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,506.92 firm fixed-price delivery order is for the supply of 4,563,957,965 Cetirizine HCL 5 mg tablets, with a performance period through March 14, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which...
This federal contract award, with the ID SPE2DB20D2200|SPE2DB24FX12T, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,386.09 firm fixed-price delivery order is for the supply of 4,565,871,652 units of Cetirizine HCL 5 mg tablets. The contract has an ultimate completion date of September 20, 2024 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,896.20 firm fixed price delivery order is for the supply of 4,566,256,766 Cetirizine HCL 5 mg tablets in 100-count bottles. The contract has an ultimate completion date of October 30, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,197.91 firm-fixed-price delivery order is for the supply of 4,562,549,817 units of Cetirizine HCL 5 mg tablets. The contract has an ultimate completion date of October 23, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
This federal contract award, identified as SPE2DB20D3101|SPE2DB25FRHW5, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,271.88 firm fixed-price delivery order is for the supply of 4,568,044,739 units of Cetirizine HCl 5 mg tablets. The contract has an ultimate completion date of April 28, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
This federal contract award, with ID SPE2DB22D1002|SPE2DB25FKXQ8, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,567,145,587 units of Cetirizine HCL 10 mg tablets in 100-count packages, with a ceiling value of $1,056.33. This is a firm-fixed-price delivery order contract with a completion date of February 5, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,780.54 firm fixed-price delivery order is for the supply of 4,566,372,069 units of Cetirizine HCL 5 mg tablets. The contract has an ultimate completion date of November 8, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,255.72 firm fixed-price delivery order is for the supply of 4,567,497,393 units of cetirizine HCl 10 mg tablets in 500-count bottles. The contract has an ultimate completion date of March 10, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB24FHX96
    Delivery Order

This federal contract award, identified as SPE2DB22D2206|SPE2DB24FHX96, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,003.52 firm fixed-price delivery order is for the supply of 4565006464 - Cetirizine HCL 5 mg tablets, with a performance period through June 27, 2024.

Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.

The subject contract award was not designated with any set-aside requirements, indicating open competition. No subcontractors are mentioned in the information provided.

Generated 5/17/25, 10:01 AM